USPTO serial 78090584
PHARMEXA
Reviewed by CopyMark Law Group
Reg. 3319312Status 710
- Filing date
- Status date
- Registration date
- Oct 23, 2007
- Examiner
- THOMAS, JULIE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with PHARMEXA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
2970 Horsholm, DK
2970 Horsholm, DK
2970 Horsholm, DK
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Cynthia Clarke Weber
CYNTHIA CLARKE WEBER SUGHRUE MION PLLC2100 PENNSYLVANIA AVE NWWASHINGTON, DC 20037-3202UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical products for use in the development of pharmaceuticals, vaccines, namely, therapeutic, subcomponent, polypeptide and live vaccines, viral and nucleic acids vaccines, DNA vaccines, vaccine excipients, vaccine carriers, and vaccine adjuvants for medical science; chemical preparations for analyses in laboratories for in vivo analyses for medical purposes; non-pathogenic microorganisms and vira for vaccine use, polypeptides, protein and nucleic acids, including DNA for vaccine use | SECTION 8 - CANCELLED | May 1, 2003 |
| 005 | Pharmaceutical preparations and substances for the treatment of neoplastic disorders, inflammatory disorders, infectious diseases, traumatic disorders, metabolic disorders, hematologic respiratory disorders, vascular and cardial disorders, endocrinologic disorders, muscular disorders, skeletal and bone disorders, neurological disorders, skin and mucosal disorders, psychiatric disorders, lymphatic disorders, intestinal disorders, urologic disorders, and reproductive disorders; vaccines, namely, therapeutic vaccines, subcomponent vaccines, polypeptide vaccines, live vaccines, viral vaccines, nucleic acid vaccines and DNA vaccines, vaccine recipients, vaccine carriers, vaccines adjuvants; vaccines containing non-pathogenic microorganisms and vira; vaccines containing polypeptides, protein and nucleic acids, including DNA | SECTION 8 - CANCELLED | May 1, 2003 |
| 042 | Scientific, industrial biotechnological and biomedical research; pharmaceutical, biomedical and biotecnological development of therapeutic vaccines, other vaccines and pharmaceuticals; chemical, biochemical and molecular biological analyses; medical and scientific research, namely, in vitro and in vivo preclinical tests of potential drugs; medical and scientific research, namely, in vitro and in vivo research concerning therapeutic vaccines, other vaccines and potential drugs; scientific, industrial biotechnological and biomedical consultancy concerning the above analyses, tests and research; biomedical and pharmaceutical clinical testing and research | SECTION 8 - CANCELLED | May 1, 2003 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Pharmexa A/S
- Other trademarks owned by Pharmexa A/S
- Other trademarks owned by Pharmexa A/S
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named PHARMEXA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 30, 2014 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Oct 23, 2007 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 19, 2007 | REGV | LAW OFFICE REGISTRATION REVIEW COMPLETED | — |
| Sep 19, 2007 | ALIE | ASSIGNED TO LIE | — |
| Aug 14, 2007 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jul 30, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 3, 2007 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Mar 26, 2007 | IUAF | USE AMENDMENT FILED | — |
| Mar 26, 2007 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Sep 25, 2006 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Sep 25, 2006 | EXT3 | SOU EXTENSION 3 FILED | — |
| Sep 25, 2006 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 2, 2006 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 2, 2006 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 2, 2006 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 26, 2005 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 1, 2005 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 1, 2005 | PAPER RECEIVED | — | |
| May 3, 2005 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 23, 2005 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Sep 10, 2004 | CFIT | CASE FILE IN TICRS | — |
| Apr 15, 2003 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Mar 4, 2003 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 12, 2003 | NPUB | NOTICE OF PUBLICATION | — |
| Dec 30, 2002 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 6, 2002 | REIN | REINSTATED | — |
| Nov 18, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 5, 2002 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 25, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 28, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 25, 2002 | DOCK | ASSIGNED TO EXAMINER | — |